Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY7.70 CNY
Change Today -0.86 / -10.05%
Volume 9.7M
000597 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 1:30 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

northeast pharmaceutical-a (000597) Snapshot

Open
CNY7.98
Previous Close
CNY8.56
Day High
CNY8.18
Day Low
CNY7.70
52 Week High
06/16/15 - CNY17.80
52 Week Low
07/7/15 - CNY7.70
Market Cap
3.7B
Average Volume 10 Days
16.9M
EPS TTM
CNY-0.04
Shares Outstanding
474.7M
EX-Date
05/2/13
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NORTHEAST PHARMACEUTICAL-A (000597)

Related News

No related news articles were found.

northeast pharmaceutical-a (000597) Related Businessweek News

No Related Businessweek News Found

northeast pharmaceutical-a (000597) Details

Northeast Pharmaceutical Group Co., Ltd. provides chemical synthetic and bio-fermentation APIs, and medicinal and micro-ecological preparation products in China. It offers various nutritional products, such as Vitamin C, L-Carnitine, and other products for customers in food, beverage, and health industries; API products comprising fosfomycin, anti HIV, and other products; and chemical products, including chemical and pharmaceutical intermediates, and chiral separation reagent products. The company also provides healthcare products, such as dietary supplements; prescription and OTC products, including antibiotics and antibacterials, antipyretic analgesics, antivirus, antidiabetic, antitussive, cardio-cerebral-vascular, gastrointestinal, narcotic and psychoactive, and urological drugs; and OEM products comprising effervescent tablets, granules, syrup, capsules, pellets, etc. In addition, it distributes various medical products, such as vitamins, amino acids, nutrition supplements, sweetness, etc. in North America, South America, Europe, Africa, Southeast Asia, etc. Northeast Pharmaceutical Group Co., Ltd. was founded in 1946 and is based in Shenyang, China.

Founded in 1946

northeast pharmaceutical-a (000597) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

northeast pharmaceutical-a (000597) Key Developments

Northeast Pharmaceutical Group Co., Ltd. to Report Q1, 2015 Results on Apr 28, 2015

Northeast Pharmaceutical Group Co., Ltd. announced that they will report Q1, 2015 results on Apr 28, 2015

Northeast Pharmaceutical Group Co., Ltd., Annual General Meeting, Apr 27, 2015

Northeast Pharmaceutical Group Co., Ltd., Annual General Meeting, Apr 27, 2015., at 09:30 China Standard Time. Agenda: To consider 2014 work report of the board of directors; to approve 2014 work report of the supervisory committee; to consider 2014 annual report and its summary; to consider 2014 financial resolution report; to approve special report on storage and use of raised funds; to consider 2014 internal control self-evaluation report; to consider reappointment of 2015 audit firm; to approve 2014 profit distribution plan; to consider determination of the scope for 2015 financing total quota; to consider purchase of wealth management products with security assurance funds; to approve issuance of medium-term notes; to consider capital increase in subsidiaries; and to consider write-off of assets losses.

Northeast Pharmaceutical Reports Earnings Results for the Year 2014

Northeast Pharmaceutical reported earnings results for the year 2014. The company recorded annual operating income of CNY 4.333 billion, growing 11.96% year on year. Net profits attributable to shareholders reached CNY 87.075 million, surging 152.15%. Basic earnings per share were CNY 0.22.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000597:CH CNY7.70 CNY -0.86

000597 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000597.
View Industry Companies
 

Industry Analysis

000597

Industry Average

Valuation 000597 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.9x
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NORTHEAST PHARMACEUTICAL-A, please visit www.nepharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.